🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

I’m thrilled by the publication of our Nature Cancer paper using #AI analysis of #multiomic datasets to predict outcomes in #pancreaticcancer patients. This work is the unveiling of the #CedarsSinaiCancer #MolecularTwin. #PDAC Cedars-Sinai Academic Medicine Convergent Science Virtual Cancer Center cedars-sinai.org/newsroom/cedar…

Novel Molecular Twin Tool May Improve Precision Medicine Care in Patients With Pancreatic Cance - goo.gl/alerts/DnGkZj #GoogleAlerts

Highlighting seminal work from #KOL speakers at the 5th Annual Cancer at Cedars-Sinai GI Tumor Conf: Nicholas Nissen: Circulating cells/oncosomes in portal/periph blood for monitoring resectable #PDAC pubmed.ncbi.nlm.nih.gov/38360856/ Mar 23, 2024. Register at cedars.cloud-cme.com/course/courseo… OncoAlert

Highlighting seminal work from #KOL speakers at the 5th Annual Cancer at Cedars-Sinai GI Tumor Conf: Dr. Oliver Maddocks: #aminoacid restriction as a novel #PDAC therapeutic strategy pubmed.ncbi.nlm.nih.gov/28425994/ Mar 23, 2024. Register at cedars.cloud-cme.com/course/courseo… OncoAlert CME Program at Cedars-Sinai

#CedarsSinaiCancer is excited to host the upcoming 5th Annual #GI Tumor Conference on 3/23. Register today! This will be led by course directors Dr. Andrew Hendifar, Jun Gong & Arsen Osipov, MD. #CedarsSinai #Gastroenterology #tumor CME Program at Cedars-Sinai Cedars-Sinai Academic Medicine cmecshs.org/gitumor2024

Did you know? When caught early, colorectal cancer has a 90% survival rate. Sharing this post from @coloncancercoalition they have great resources available ➡️ coloncancercoalition.org

So cool, colleague pointed this out to me today. Unexpected! But deeply honored to be on the cover OncLive.com with esteemed #GI onc colleagues Anthony El-Khoueiry Rachna Shroff, MD, MS, FASCO Anwaar Saeed Anne Covey MD FSIR Dr. Michael Morse onclive.com/publications/o… Cancer at Cedars-Sinai

The (almost) full program is now online with an amazing lineup of speakers! #AACRPan24 Eileen M O’Reilly Mancias Lab Jash Datta, MD Teresa Zimmers Dr. Andrew Hendifar Tobias Janowitz Wantong Yao Mara Sherman Lab KenOliveLab Andrew Aguirre Channing Der Bryant Lab UNC Erica D. Pratt Michael Goggins

@acabutcher

Our fantastic Cedars-Sinai Academic Medicine resident Murtaza Ahmed presenting our work Dr. Andrew Hendifar Jun Gong Cristina Ferrone Cancer at Cedars-Sinai on impact of germline DDR mutations in neoadjuvantly treated PDAC.

High frequency of germline variants in CFTR identified in PDAC patient... sciencedirect.com/science/articl…. interesting finding in pdac patients who had testing for pancreatitis associated germline variants. Arsen Osipov, MD

🚨🚨Hot off the press NEJM In a randomized Ph II Ponsegromab, an anti-GDF15 mAB, increased weight gain, overall physical activity and reduced cachexia symptoms in patients with #cachexia and ⬆️ GDF-15 nejm.org/doi/full/10.10…

As this novel approach to improving weight and performance continues to develop, cancer patients will finally get an opportunity to look and feel like their “old selves”. A great moment for cancer care. ESMO - Eur. Oncology NEJM Pfizer Inc.

RMC-9805 Triggers Tumor Regressions in KRAS G12D–Mutant Pancreatic Cancer onclive.com/view/rmc-9805-… via OncLive.com

Understanding and Treating Pancreatic Cancer Cachexia | Blog | AACR - goo.gl/alerts/gCyikP #GoogleAlerts. Addressing cancer associated weight loss will become a pillar of cancer care in the near future. #PancreaticCancer Cancer at Cedars-Sinai

Pancreatic Cancer Surge May Be Less Worrisome Than It Seemed - The New York Times. nytimes.com/2024/11/18/hea…

Nivolumab plus Ipilimumab in Microsatellite-Instability–High Metastatic Colorectal Cancer | New England Journal of Medicine nejm.org/doi/full/10.10…. Dual checkpoint inhibition with unprecedented outcomes in MSI-High colorectal cancer. A new standard of care.

We have compared the performance ctDNA by Natera vs. imaging in curatively resected colorectal cancer on surveillance. Signatera missed 31% of recurrences (+ imaging and negative Signatera). Largest study of comparative strategies. jamanetwork.com/journals/jaman…

Today is #WorldCancerDay thank you KTLA for this interview & raising cancer awareness Lu Parker Glen Walker Cancer at Cedars-Sinai OncoAlert LARVOL Open Oncology OncoDaily 𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏 Kate Sears MOASC OncoReporte Cancer Links Oncology Brothers ktla.com/video/doctor-j…

Morning run with ⁦Noah merrin⁩, And Hyung Kim ⁦Cedars-Sinai⁩ 2025 Faculty retreat. Stopping for pics is the only way to keep up with Zab Mosenifar. ⁦⁩ ⁦⁦Cedars-Sinai Academic Medicine⁩